The human vagina is a principal entry and transmission site for sexually transmitted pathogens including HIV-1, yet little information is available concerning influences of endogenous and exogenous factors on vaginal mucosal immune defense mechanisms or other parameters affecting vaginal infection. We propose to test the hypothesis that reproductive hormones, intercourse and intravaginal products affect the transmission rate of HIV- 1 through alterations in vaginal defense mechanisms, specifically by: l) inhibition of vaginal humoral, cellular or innate immune defense mechanisms; 2) enhancement of susceptibility to pathogen infection through improved access to target cells and/or their activation, and/or 3) enhancement of HIV-1 production through activation of infected cells in the vagina. RT-PCR, ELISA and immunohistology techniques will be utilized to better define immune defense mechanisms of the normal human vagina. Lymphocyte and inflammatory cell populations, and their products (immunoglobulins, cytokines, activation and adhesion molecules) will be assessed in surgical specimens from various regions of the vagina and cervicovaginal lavage specimens (CVLs) obtained: 1) throughout the menstrual cycle, 2) throughout pregnancy and the postpartum period, 3) post menopause with and without estrogen replacement, 4) following intercourse or administration of seminal components, and 5) following administration of intravaginal products. Similar CVL data will be attained for HIV-1 infected women (WITS cohort) and correlated with HIV-1 titers in CVLs assessed by quantitative HIV culture and PCR methods. In addition, studies will be performed to further document effects of cervicovaginal secretions, taken from the conditions listed above, on immune function and HIV-1 infectivity in vitro. This study is designed to provide a foundation for the development of vaccines and other strategies against sexually transmitted pathogens.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD033205-04
Application #
2673881
Study Section
Special Emphasis Panel (SRC (17))
Project Start
1995-05-01
Project End
2000-04-30
Budget Start
1998-05-01
Budget End
2000-04-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Pudney, Jeffrey; Quayle, Alison J; Anderson, Deborah J (2005) Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 73:1253-63
Gargiulo, Antonio R; Fichorova, Raina N; Politch, Joseph A et al. (2004) Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles. Fertil Steril 82 Suppl 3:1226-34
Fichorova, R N; Tucker, L D; Anderson, D J (2001) The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 184:418-28
Vassiliadou, N; Tucker, L; Anderson, D J (1999) Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro. J Immunol 162:7510-8
Fichorova, R N; Anderson, D J (1999) Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 60:508-14
Livingston, J B; Lu, S; Robinson, H et al. (1998) Immunization of the female genital tract with a DNA-based vaccine. Infect Immun 66:322-9
Anderson, D J; Politch, J A; Tucker, L D et al. (1998) Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. AIDS Res Hum Retroviruses 14 Suppl 1:S43-9
Haimovici, F; Mayer, K H; Anderson, D J (1997) Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions. J Acquir Immune Defic Syndr Hum Retrovirol 15:185-91
Fichorova, R N; Rheinwald, J G; Anderson, D J (1997) Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod 57:847-55